一种治疗糖尿病的中药组合物及其制备方法
The oral liquid preparation, formed by scientifically combining Rehmannia glutinosa and other traditional Chinese medicine ingredients, solves the safety and effectiveness problems of existing diabetes treatments, achieves significant blood sugar reduction and improves insulin resistance, and promotes the comprehensive recovery of diabetic patients.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUNAN ANHESHOU PHARM CO LTD
- Filing Date
- 2025-10-15
- Publication Date
- 2026-07-17
AI Technical Summary
Existing diabetes treatments carry risks of hypoglycemia, liver and kidney damage, and negative effects on intestinal function. Traditional Chinese medicine has not yet fully utilized its unique advantages in diabetes treatment.
A traditional Chinese medicine composition, including Rehmannia glutinosa, Cornus officinalis, Ophiopogon japonicus, Dioscorea opposita, Phragmites communis, Schisandra chinensis, Paeonia suffruticosa, and Pueraria lobata, is scientifically formulated into an oral liquid preparation to regulate glucose and lipid metabolism, improve insulin resistance, and promote tissue repair.
It has a significant hypoglycemic effect, improves insulin resistance, promotes patient recovery, and is simple to prepare, making it easy to produce on a large scale. It avoids the problem of drug residue precipitation in traditional Chinese medicine preparations, and has high safety and stable efficacy.
Smart Images
Figure SMS_1 
Figure SMS_2 
Figure SMS_3